Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center-Reference-Cited by-同舟云学术

Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center

Published:2008-07-04 Issue:11 Volume:27 Page:1101-1111
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Leitão J. H.,Sousa S. A.,Cunha M. V.,Salgado M. J.,Melo-Cristino J.,Barreto M. C.,Sá-Correia I.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-008-0552-0.pdf

Reference29 articles.

1. Mahenthiralingam E, Urban TA, Goldberg JB (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3:144–156

2. LiPuma JJ (2003) Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 24:681–692

3. Speert DP (2002) Advances in Burkholderia cepacia complex. Paediatr Respir Rev 3:230–235

4. Collins FS (1992) Cystic fibrosis: molecular biology and therapeutic implications. Science 256:774–779

5. Cunha MV, Leitão JH, Mahenthiralingam E, Vandamme P, Lito L, Barreto C, Salgado MJ, Sá-Correia I (2003) Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol 41:4113–4120

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial Activity of a Natural Clay Mineral against Burkholderia cepacia Complex and Other Bacterial Pathogens Isolated from People with Cystic Fibrosis;Microorganisms;2023-01-06

2. TheBurkholderia contaminansprevalent phenotypes as possible markers of poor clinical outcomes in chronic lung infection of children with cystic fibrosis;Pathogens and Disease;2023

3. The anti-virulence activity of the non-mevalonate pathway inhibitor FR900098 towards Burkholderia cenocepacia is maintained during experimental evolution;Microbiology;2022-03-31

4. Türkiyede Üçüncü Basamak bir Hastanede Son On Yılda Burkholderia Türlerinin Antibiyotik Dirençlerinin Değerlendirilmesi;Flora the Journal of Infectious Diseases and Clinical Microbiology;2022-03-25

5. A Polyclonal Antibody Raised against the Burkholderia cenocepacia OmpA-like Protein BCAL2645 Impairs the Bacterium Adhesion and Invasion of Human Epithelial Cells In Vitro;Biomedicines;2021-11-29